Diabetes Education and Support for Type 2 Diabetes
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how a nurse-led phone-based program can help older African Americans better manage type 2 diabetes. Participants will receive diabetes education and support to address unmet social needs, aiming to improve health and well-being. One group will participate in monthly phone sessions as part of the DM Social Needs Intervention, which combines diabetes education, skills training, and social needs resolution. The other group will receive diabetes information by mail as part of Usual Care. Suitable candidates for this trial are individuals aged 50 or older, identifying as African American, with poorly controlled type 2 diabetes, often indicated by an A1C level of 8% or higher. As an unphased trial, this study provides a unique opportunity to contribute to innovative research aimed at improving diabetes management in the community.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this intervention is safe for older African Americans with poorly controlled type 2 diabetes?
Research has shown that the DM Social Needs intervention is being studied for its effectiveness in managing type 2 diabetes. This program combines diabetes education with skills training and addresses social needs. However, there is limited direct evidence about its safety from available sources.
This intervention is not a new drug or medical procedure. Instead, it is a structured support program delivered over the phone by a trained health educator. Programs like this are generally considered safe because they focus on education and support, not on introducing new medications or treatments. Typically, these programs have a very low risk of causing harm.
Since the trial tests an educational and support approach rather than a new drug or medical procedure, it is reasonable to expect that the intervention is well-tolerated. The goal is to help participants manage their diabetes better through education and addressing social needs, which can improve health outcomes without posing significant safety risks.12345Why are researchers excited about this trial?
Researchers are excited about the DM Social Needs intervention because it offers a personalized and holistic approach to managing Type 2 Diabetes. Unlike standard care, which typically involves medication and general educational materials, this intervention provides one-on-one support through monthly telephone sessions with a trained health educator. These sessions focus not only on diabetes education and skills training but also address social needs, helping to solve real-life challenges that can impact diabetes management. This tailored, supportive method could lead to more effective diabetes control and improved quality of life for patients.
What evidence suggests that this trial's treatments could be effective for type 2 diabetes?
Research has shown that combining diabetes education with practical skills training and addressing social needs can improve diabetes management. In this trial, participants in the DM Social Needs Intervention arm will receive specific education and support, which studies have found often leads to better blood sugar control. The DM Social Needs program also addresses unmet social needs, which can significantly impact health. In similar programs, patients reported feeling more empowered and saw improvements in managing their diabetes. Early results suggest this approach could be especially beneficial for older African Americans with poorly controlled type 2 diabetes. Meanwhile, participants in the Usual Care arm will receive diabetes education materials recommended by the American Diabetes Association.12345
Who Is on the Research Team?
Aprill Z Dawson, PhD, MPH
Principal Investigator
Medical College of Wisconsin
Are You a Good Fit for This Trial?
This trial is for African Americans aged 50 or older with poorly controlled type 2 diabetes (HbA1C levels of at least 8%). Participants must self-identify as Black and have a diagnosis of T2DM. Those with significant dementia, involvement in other diabetes trials, substance abuse issues, or a life expectancy less than six months cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the DM Social Needs intervention, including diabetes education and skills training, and resolution of social needs via telephone
Follow-up
Participants are monitored for changes in glycemic control and other outcomes after the intervention
What Are the Treatments Tested in This Trial?
Interventions
- DM Social Needs
- Usual Care
Find a Clinic Near You
Who Is Running the Clinical Trial?
Medical College of Wisconsin
Lead Sponsor